Next Stage Two: Navigating Cross-Species Commercialisation to Scale Immunity from Bees to Shrimp | Kisaco Research

Bringing the world’s first insect vaccine from discovery to commercial reality marks a defining milestone for Dalan Animal Health. Annette Kleiser, CEO, shares how Dalan is now applying its innate immunity platform to aquaculture, advancing proof-of-concept in shrimp, and exploring broader species application.

Session Topics: 
Aquaculture
Scale
Bee
Vaccine
Platform
Proof-of-Concept
Speaker(s): 

Author:

Annette Kleiser

CEO
Dalan

Annette Kleiser

CEO
Dalan
Time: 
1.05pm - 1.25pm
Agenda Track No.: 
Track 3
Summary: 
Session Will be Recorded - Attend live or Watch On-Demand
Session Type: 
General Session (Presentation)